000 | 01118 a2200301 4500 | ||
---|---|---|---|
005 | 20250517162525.0 | ||
264 | 0 | _c20180502 | |
008 | 201805s 0 0 eng d | ||
022 | _a1347-5215 | ||
024 | 7 |
_a10.1248/bpb.b17-00243 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNakagawa, Takayuki | |
245 | 0 | 0 |
_aRoles of Transient Receptor Potential Ankyrin 1 in Oxaliplatin-Induced Peripheral Neuropathy. _h[electronic resource] |
260 |
_bBiological & pharmaceutical bulletin _c2017 |
||
300 |
_a947-953 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aOrganoplatinum Compounds _xadverse effects |
650 | 0 | 4 | _aOxaliplatin |
650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xchemically induced |
650 | 0 | 4 |
_aTRPA1 Cation Channel _xphysiology |
700 | 1 | _aKaneko, Shuji | |
773 | 0 |
_tBiological & pharmaceutical bulletin _gvol. 40 _gno. 7 _gp. 947-953 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1248/bpb.b17-00243 _zAvailable from publisher's website |
999 |
_c27335200 _d27335200 |